PRKAA2 and diabetes mellitus: Interestingly, AMPK activation (p‐AMPK) has been shown to attenuate LPS‐induced BBB disruption in vitro (Zhao et al., 2014) and protect the BBB in diabetes by inhibiting LPS‐enhanced NADPH oxidase expression in brain capillary endothelial cells (Liu et al., 2012).